Company Financials

Innovent Biologics, Inc. Financials

Hong Kong dollar

business Innovent Biologics, Inc. Company Profile

Main Stock Listing

HKEX: 1801

Market Capitalization HK$51.95 Billion as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE -49.02
Forward PE 290.00
Price to Sales TTM HK$6.97
Price to Book MRQ HK$4.18
Enterprise to Revenue 6.13
Enterprise to EBITDA -46.12

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2023-12-31
Profit Margin -17.18%
Operating Margin -10.94%
Return on Assets TTM -4.18%
Return on Equity TTM -11.04%

Income Statement

Revenue TTM HK$8,002,981,992
Revenue per Share TTM HK$4.65
Quarterly Revenue Growth 46.30%
Gross Profit TTM HK$5,728,272,739
EBITDA HK$-1,063,171,796
Net Income to Common TTM HK$-1,375,235,058
Diluted EPS TTM HK$-0.86
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ HK$9,260,742,763
Total Cash per Share MRQ HK$5.30
Total Debt MRQ HK$
Total Debt to Equity MRQ 26.95
Current Ratio MRQ 2.68
Book Value per Share MRQ HK$7.63

Cash Flow

Operating Cash Flow TTM HK$595,721,225
Levered Free Cash Flow TTM HK$-189,324,181

1801 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 1,628,409,984
Float Shares 1,418,592,482
Avg 10 Volume 14,051,440
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 6.78%
% Held by Institutions 47.05%

Stock Price Summary

Beta 0.25
Fifty Two Week Low HK$28.30
Fifty Two Week High HK$52.15
Fifty Two Week Change -3.71%
Day 50 MA HK$36.17
Day 200 MA HK$39.12

Dividends and Splits

Forward Annual Dividend Rate HK$
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate HK$0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date